Veru
VERU
#10494
Rank
NZ$72.45 M
Marketcap
NZ$4.25
Share price
1.24%
Change (1 day)
-30.14%
Change (1 year)

Earnings for Veru (VERU)

Earnings in 2026 (TTM): -NZ$47.96 Million

According to Veru's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$52.27 Million, an increase over its 2024 earnings that were of -NZ$66.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Veru from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$47.96 Million-8.24%
2025 -NZ$52.27 Million-21.84%
2024 -NZ$66.88 Million-49.67%
2023 -NZ$0.14 Billion-31.87%
2022 -NZ$0.2 Billion673.72%
2021 -NZ$25.21 Million-375.47%
2020 NZ$9.14 M-157.74%
2019 -NZ$15.85 Million-32.09%
2018 -NZ$23.34 Million1.17%
2017 -NZ$23.07 Million-1349.01%
2016 NZ$1.84 M-85.97%
2015 NZ$13.16 M99.18%
2014 NZ$6.6 M-51.18%
2013 NZ$13.53 M-33.9%
2012 NZ$20.47 M108.3%
2011 NZ$9.83 M3.75%
2010 NZ$9.47 M-20.61%
2009 NZ$11.93 M136.88%
2008 NZ$5.03 M
2006 -NZ$0.14 Million26.36%
2005 -NZ$0.11 Million
2000 -NZ$3.82 Million
1998 -NZ$5.14 Million-37.72%
1997 -NZ$8.26 Million-47.64%
1996 -NZ$15.77 Million37.12%
1995 -NZ$11.5 Million-15.38%
1994 -NZ$13.59 Million875%
1993 -NZ$1.4 Million-50%
1992 -NZ$2.79 Million-0%
1991 -NZ$2.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.4 Billion 713.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$31.63 Million-35.46%๐Ÿ‡บ๐Ÿ‡ธ USA